Operating Segments (Tables)

The following table presents selected financial information and significant segment expenses for the periods presented (in thousands):


	Fiscal Quarter Ended				Fiscal Year-To-Date Ended
	June 26, 2026		June 27, 2025		June 26, 2026		June 27, 2025
Total revenue	$	304,995	$	315,546	$	1,047,331	$	1,042,106
Less:
Cost of licensing (1)	16,128		15,103		47,754		42,474
Cost of products and services (1) (2)	16,393		21,116		57,033		54,469
Research and development expense (1) (2)	56,054		56,794		167,407		165,112
Sales and marketing expense (1) (2)	74,426		75,234		238,511		234,906
General and administrative expense (1) (2)	63,495		59,904		183,754		174,146
Restructuring charges	3,955		(547)		16,605		8,879
Stock-based compensation	30,964		30,728		98,883		97,462
Amortization of acquisition-related intangibles	9,705		10,016		29,285		30,741
Interest (income)/expense, net	(3,453)		(4,111)		(12,595)		(10,316)
Equity method investees’ net income	(5,669)		(3,727)		(14,063)		(17,129)
Other income, net (1) (3)	(805)		(480)		(346)		(455)
Income tax expense	14,588		8,974		56,754		54,979
Net income including noncontrolling interest	29,214		46,542		178,349		206,838
Less: net income attributable to noncontrolling interest	(612)		(471)		(1,505)		(1,152)
Net income attributable to Dolby Laboratories, Inc.	$	28,602	$	46,071	$	176,844	$	205,686

(1)Excludes amortization of acquisition-related intangibles presented separately.

(2)Excludes stock-based compensation expense presented separately.

(3)Excludes our proportional share of net income in our equity method investees presented separately.